126 related articles for article (PubMed ID: 28811560)
1. Evidence for the importance of post-transcriptional regulatory changes in ovarian cancer progression and the contribution of miRNAs.
Zhang M; Matyunina LV; Walker LD; Chen W; Xiao H; Benigno BB; Wu R; McDonald JF
Sci Rep; 2017 Aug; 7(1):8171. PubMed ID: 28811560
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome stability profiling using 5'-bromouridine IP chase (BRIC-seq) identifies novel and functional microRNA targets in human melanoma cells.
Joshi P; Seki T; Kitamura S; Bergano A; Lee B; Perera RJ
RNA Biol; 2019 Oct; 16(10):1355-1363. PubMed ID: 31179855
[TBL] [Abstract][Full Text] [Related]
4. Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.
Yang J; Zhou Y; Ng SK; Huang KC; Ni X; Choi PW; Hasselblatt K; Muto MG; Welch WR; Berkowitz RS; Ng SW
BMC Cancer; 2017 Jun; 17(1):422. PubMed ID: 28623900
[TBL] [Abstract][Full Text] [Related]
5. Key miRNAs and target genes played roles in the development of clear cell renal cell carcinoma.
Liu J; Liu B; Guo Y; Chen Z; Sun W; Gao W; Wu H; Wang Y
Cancer Biomark; 2018; 23(2):279-290. PubMed ID: 30198869
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA‑455 inhibits cell proliferation and invasion of epithelial ovarian cancer by directly targeting Notch1.
Xu L; Li H; Su L; Lu Q; Liu Z
Mol Med Rep; 2017 Dec; 16(6):9777-9785. PubMed ID: 29039517
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer cell line MDA-MB-231 miRNA profile expression after BIK interference: BIK involvement in autophagy.
Ruiz Esparza-Garrido R; Torres-Márquez ME; Viedma-Rodríguez R; Velázquez-Wong AC; Salamanca-Gómez F; Rosas-Vargas H; Velázquez-Flores MÁ
Tumour Biol; 2016 May; 37(5):6749-59. PubMed ID: 26662110
[TBL] [Abstract][Full Text] [Related]
8. Evidence for the complexity of microRNA-mediated regulation in ovarian cancer: a systems approach.
Shahab SW; Matyunina LV; Mezencev R; Walker LD; Bowen NJ; Benigno BB; McDonald JF
PLoS One; 2011; 6(7):e22508. PubMed ID: 21811625
[TBL] [Abstract][Full Text] [Related]
9. Integrated Analysis of Thyroid Cancer Public Datasets Reveals Role of Post-Transcriptional Regulation on Tumor Progression by Targeting of Immune System Mediators.
Geraldo MV; Kimura ET
PLoS One; 2015; 10(11):e0141726. PubMed ID: 26536459
[TBL] [Abstract][Full Text] [Related]
10. A systems biology approach for miRNA-mRNA expression patterns analysis in non-small cell lung cancer.
Najafi A; Tavallaei M; Hosseini SM
Cancer Biomark; 2016; 16(1):31-45. PubMed ID: 26484609
[TBL] [Abstract][Full Text] [Related]
11. Clinical and RNA expression integrated signature for urothelial bladder cancer prognosis.
Xiong J; Xiong K; Bing Z
Cancer Biomark; 2018 Feb; 21(3):535-546. PubMed ID: 29226853
[TBL] [Abstract][Full Text] [Related]
12. Primary and recurrent ovarian high-grade serous carcinomas display similar microRNA expression patterns relative to those of normal ovarian tissue.
Nam EJ; Kim S; Lee TS; Kim HJ; Lee JY; Kim SW; Kim JH; Kim YT
Oncotarget; 2016 Oct; 7(43):70524-70534. PubMed ID: 27655640
[TBL] [Abstract][Full Text] [Related]
13. RNASET2 silencing affects miRNAs and target gene expression pattern in a human ovarian cancer cell model.
Turconi G; Scaldaferri D; Fabbri M; Monti L; Lualdi M; Pedrini E; Gribaldo L; Taramelli R; Acquati F
Int J Oncol; 2016 Dec; 49(6):2637-2646. PubMed ID: 27840914
[TBL] [Abstract][Full Text] [Related]
14. MiR-204 down-regulation elicited perturbation of a gene target signature common to human cholangiocarcinoma and gastric cancer.
Canu V; Sacconi A; Lorenzon L; Biagioni F; Lo Sardo F; Diodoro MG; Muti P; Garofalo A; Strano S; D'Errico A; Grazi GL; Cioce M; Blandino G
Oncotarget; 2017 May; 8(18):29540-29557. PubMed ID: 28199974
[TBL] [Abstract][Full Text] [Related]
15. A systems biology approach to identify microRNAs contributing to cisplatin resistance in human ovarian cancer cells.
Liu W; Wang S; Zhou S; Yang F; Jiang W; Zhang Q; Wang L
Mol Biosyst; 2017 Oct; 13(11):2268-2276. PubMed ID: 28861582
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of dicer expression in ovarian cancer tissues.
Pampalakis G; Diamandis EP; Katsaros D; Sotiropoulou G
Clin Biochem; 2010 Feb; 43(3):324-7. PubMed ID: 19782670
[TBL] [Abstract][Full Text] [Related]
17. The transcriptomic profile of ovarian cancer grading.
Yao CQ; Nguyen F; Haider S; Starmans MH; Lambin P; Boutros PC
Cancer Med; 2015 Jan; 4(1):56-64. PubMed ID: 25314936
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA transcriptome profiling of mice brains infected with Japanese encephalitis virus by RNA sequencing.
Li XF; Cao RB; Luo J; Fan JM; Wang JM; Zhang YP; Gu JY; Feng XL; Zhou B; Chen PY
Infect Genet Evol; 2016 Apr; 39():249-257. PubMed ID: 26845346
[TBL] [Abstract][Full Text] [Related]
19. Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma.
Liep J; Kilic E; Meyer HA; Busch J; Jung K; Rabien A
PLoS One; 2016; 11(6):e0157801. PubMed ID: 27336447
[TBL] [Abstract][Full Text] [Related]
20. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.
Koshizuka K; Nohata N; Hanazawa T; Kikkawa N; Arai T; Okato A; Fukumoto I; Katada K; Okamoto Y; Seki N
Oncotarget; 2017 May; 8(18):30288-30304. PubMed ID: 28415821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
